Loading clinical trials...
Loading clinical trials...
Hepatitis C virus (HCV) infection is among the most common of all chronic liver diseases. HCV predominantly affects liver cells and causes the liver to become inflamed and damaged. This can lead to ci...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07388979 · HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus), and more
NCT04366973 · Hepatitis C Virus (HCV)
NCT02219490 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
NCT02167945 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
NCT04189627 · Hepatitis C Virus (HCV)
South Ural State Medical University /ID# 226555
Chelyabinsk
LLC Center of Targeted Therapy /ID# 239529
Domodedovo
Irkutsk Regional Center for the Prevention and Control of AIDS and Infections /ID# 229509
Irkutsk
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions